Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OGT 918 in Neuronopathic Gaucher Disease
NCT00041535Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Jul 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of miglustat in neuronopathic Gaucher disease (NGD), sponsored by National Institute of Neurological Disorders and Stroke. Started Jul 2002; status: completed.
02
Drugs
miglustat
03
Conditions
neuronopathic Gaucher disease (NGD)
Beyond the preview
Go deeper on NCT00041535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00041535.